US President Trump planning to fire FDA commissioner Marty Makary, according to WSJ citing sources

The potential firing of FDA commissioner Marty Makary by President Trump indicates a shift in the administration's stance towards health governance, particularly in the context of ongoing debates around regulatory policies. This news may create uncertainty in markets, especially in sectors linked to healthcare and pharmaceuticals, and could provoke reactions in risk assets as investors gauge the implications for regulatory consistency and future health initiatives.